Amicus Therapeutics logo
Amicus Therapeutics FOLD
$ 9.76 -2.06%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Amicus Therapeutics Financial Statements 2011-2024 | FOLD

Annual Financial Statements Amicus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.86 B 3.95 B 2.55 B 4.9 B 2.18 B 2.17 B 2.46 B 1.22 B 664 M 572 M 145 M 167 M 226 M

Shares

295 M 289 M 271 M 259 M 240 M 186 M 153 M 226 M 110 M 74.4 M 51.3 M 45.6 M 34.6 M

Historical Prices

13.1 13.7 9.41 18.9 8.84 12 16.2 5.5 6.04 7.69 2.73 3.8 6.5

Net Income

-152 M -237 M -250 M -277 M -356 M -349 M -284 M -200 M -132 M -68.9 M -59.6 M -48.8 M -44.4 M

Revenue

399 M 329 M 306 M 261 M 182 M 91.2 M 36.9 M 4.96 M - 1.22 M 363 K 18.4 M 21.4 M

Cost of Revenue

37.3 M 38.6 M 34.5 M 31 M 22 M 14.4 M 6.24 M 833 K - - - - -

Gross Profit

362 M 291 M 271 M 230 M 160 M 76.8 M 30.7 M 4.12 M - - 363 K - 21.4 M

Operating Income

-77.2 M -212 M -206 M -247 M -304 M -329 M -442 M -182 M -130 M -68.7 M -64.2 M -52.9 M -50.9 M

Interest Expense

50.1 M 37.1 M 32.5 M 22.4 M 18.9 M 22.4 M 17.2 M 5.4 M 1.58 M 1.48 M 46 K 89 K 148 K

EBITDA

-69.3 M -207 M -200 M -238 M -296 M -321 M -207 M -179 M -124 M -67.1 M -60.5 M -51.2 M -49.3 M

Operating Expenses

439 M 503 M 477 M 477 M 461 M 402 M 242 M 186 M 126 M 69.9 M 62.6 M 71.3 M 72.3 M

General and Administrative Expenses

275 M 213 M 193 M 156 M 170 M 127 M 88.7 M 71.2 M 47.3 M 20.7 M 18.9 M 19.4 M 19.9 M

All numbers in USD currency

Quarterly Income Statement Amicus Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

305 M 304 M 294 M 296 M 293 M 291 M 281 M 289 M 292 M 288 M 279 M 267 M 266 M 264 M 262 M 259 M 258 M 257 M 255 M 255 M 238 M 214 M 189 M 189 M 189 M 176 M 167 M 161 M 143 M 143 M 143 M 141 M 129 M 125 M 125 M 119 M 100 M 95.7 M 95.6 M 78.9 M 67.2 M 64.4 M 62 M 49.6 M 49.6 M 49.6 M 49.6 M 48.5 M 46.9 M 37.9 M 34.7 M 35 M 34.5 M 34.5 M

Net Income

-6.73 M -15.7 M - -21.6 M -43.2 M -52.9 M - -33.3 M -62.2 M -85.3 M - -50.3 M -51.2 M -65.7 M -71.4 M -64 M -52.5 M -88.9 M -89.7 M -61.8 M -84.6 M -120 M -78.1 M -159 M -61.8 M -49.9 M -69.2 M -112 M -48.1 M -55 M -58.6 M -46.7 M -51 M -43.7 M -42.9 M -37.8 M -27.1 M -24.3 M -21.2 M -17.1 M -14.6 M -15.9 M -12.2 M -14.6 M -15.3 M -17.5 M -10 M -16.3 M -9.34 M -13.1 M -8.66 M -9.76 M -12.6 M -13.4 M

Revenue

142 M 127 M - 104 M 94.5 M 86.3 M - 81.7 M 80.7 M 78.7 M - 79.5 M 77.4 M 66.4 M 70.6 M 67.4 M 62.4 M 60.5 M 55.3 M 48.8 M 44.1 M 34 M 32.6 M 20.6 M 21.3 M 16.7 M - 10.9 M 7.16 M 4.17 M - - - - - - - - - 293 K 475 K 456 K - 39 K - - - 18.4 M 10.6 M 7.77 M - 5.8 M 4.04 M 5.97 M

Cost of Revenue

13.3 M 11.3 M - 9.95 M 9.11 M 6.94 M - 13.4 M 8.2 M 7.58 M - 11.7 M 8.38 M 6.54 M - 8.4 M 6.68 M 6.55 M - 5.6 M 5.37 M 4.06 M - 4.31 M 3.14 M 2.62 M - 1.79 M 1.06 M 775 K - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

128 M 115 M - 93.6 M 85.4 M 79.3 M - 68.3 M 72.5 M 71.1 M - 67.8 M 69 M 59.9 M - 59 M 55.7 M 54 M - 43.2 M 38.8 M 30 M - 16.3 M 18.2 M 14.1 M - 9.08 M 6.1 M 3.39 M - 1.78 M - - - - - - - - - - - - - - - - - - - - - -

Operating Income

21.7 M 15 M - -17 M -18.9 M -37.6 M - -33.8 M -60.6 M -75.3 M - -42.4 M -38.8 M -53.1 M - -52.8 M -51.3 M -78.1 M - -57.3 M -76.4 M -81.3 M - -156 M -46.9 M -56.2 M - -275 M -47.1 M -52 M - -44.9 M -48.5 M -43 M - -38 M -26.9 M -24.1 M - -16.8 M -14.3 M -15.6 M - -15.1 M -16 M -17.3 M - -16.9 M -9.35 M -10.7 M - -13.1 M -14.7 M -10 M

Interest Expense

-3.26 M -3.72 M - 3.83 M -10.9 M 11.8 M - 9.62 M 8.26 M 8.15 M - 8.16 M 8.15 M 7.99 M - 6.78 M 3.64 M 3.73 M - 4.03 M 4.62 M 6.45 M - 4.72 M 4.56 M 4.49 M - 4.35 M 4.18 M 4.29 M - 1.52 M 1.06 M 945 K - 17 K 338 K 372 K - 377 K 374 K 355 K - 7 K 9 K 10 K - 19 K 15 K 43 K - 32 K 41 K 48 K

EBITDA

23.8 M 17.1 M - -14.8 M -16.7 M -36.4 M - -32.6 M -59.3 M -73.9 M - -40.9 M -37.3 M -51.5 M - -50.3 M -49.3 M -76.3 M - -56.2 M -75.3 M -80.3 M - -155 M -46 M -55.2 M - -274 M -46.2 M -51.2 M - -44 M -47.8 M -42.3 M - -37.6 M -26.6 M -23.6 M - -16.4 M -13.9 M -15.2 M - -14.7 M -15.6 M -16.8 M - -16.5 M -8.9 M -10.3 M - -12.8 M -14.3 M -9.56 M

Operating Expenses

107 M 100 M - 111 M 104 M 117 M - 102 M 133 M 146 M - 110 M 108 M 113 M - 112 M 107 M 132 M - 100 M 115 M 111 M - 172 M 65.1 M 70.3 M - 284 M 53.2 M 55.4 M - 46.7 M 48.5 M 43 M - 38 M 26.9 M 24.1 M - 17.1 M 14.7 M 16.1 M - 15.2 M 16 M 17.3 M - 16.9 M 20 M 18.5 M - 18.9 M 18.8 M 16 M

General and Administrative Expenses

75.1 M 73.6 M - 65.7 M 65.4 M 74 M - 47.3 M 53.4 M 58.1 M - 46.1 M 42.3 M 46.7 M - 37.8 M 34.7 M 40.2 M - 39.7 M 42.6 M 44.3 M - 31.9 M 29.2 M 27.4 M - 21.6 M 19.3 M 19.1 M - 17.5 M 19.3 M 15.7 M - 15.4 M 8.28 M 6.43 M - 5.27 M 4.75 M 5.18 M - 4.64 M 4.83 M 4.82 M - 5 M 5.82 M 4.1 M - 4.84 M 6.72 M 4.4 M

All numbers in USD currency